Skip to content

Peptide library / Bones & muscles / ACE-031

In clinical trialsBones & muscles

ACE-031

A decoy receptor tested for muscle diseases, stopped after bleeding side effects.

Body system
Bones & muscles
Status
In clinical trials
Strongest evidence
Animals
Also known as
–

Effects studied or claimed

What it is used or promoted for, and where each effect has actually been seen

  • Muscle growth in Duchenne muscular dystrophySmall human studies

How it is thought to work

ACE-031 captured myostatin and related proteins to allow muscle growth, but also affected other signaling.

What the evidence shows

Early trials showed small gains in lean mass in healthy women, but a trial in boys with Duchenne was stopped in 2010.

Safety and unknowns

Nosebleeds and gum bleeding led to trial suspension.

Regulatory status

Not approved. Development ended.

Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.

More in Bones & muscles

General information, not medical advice. Do not buy or inject unregulated peptides.